National Planning Corporation’s iShares US Pharmaceuticals ETF IHE Stock Holding History

National Planning Corporation’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-7,689	Closed	-$343K	–	672
2016 Q1	$343K	Sell	7,689 -28,836	-79%	-$1.35M	0.03%	442
2015 Q4	$1.68M	Sell	36,525 -8,775	-19%	-$462K	0.14%	171
2015 Q3	$2.42M	Buy	45,300 +13,323	+42%	+$764K	0.22%	99
2015 Q2	$1.87M	Buy	31,977 +19,695	+160%	+$1.15M	0.17%	130
2015 Q1	$695K	Sell	12,282 -1,854	-13%	-$101K	0.06%	270
2014 Q4	$722K	Buy	14,136 +300	+2%	+$14.6K	0.05%	310
2014 Q3	$655K	Sell	13,836 -150	-1%	-$6.77K	0.05%	337
2014 Q2	$630K	Buy	13,986 +432	+3%	+$18.6K	0.05%	342
2014 Q1	$576K	Hold	13,554	–	–	0.05%	335
2013 Q4	$533K	Buy	13,554 +2,178	+19%	+$81.7K	0.05%	347
2013 Q3	$407K	Buy	11,376 +1,401	+14%	+$49.3K	0.04%	400
2013 Q2	$329K	Buy	+9,975	New	+$331K	0.04%	369

Other funds holding IHE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Spinnaker Trust Portland, Maine $2.06B AUM 24.94% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

EAMA

EFG Asset Management (Americas) Miami, Florida $579M AUM 24.22% 1-Year Est. Return

National Planning Corporation's IHE Position: Q2 2016 in Review

National Planning Corporation sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2016, closing a stake of 7,689 shares — an estimated $343K sold.

National Planning Corporation first reported a position in IHE in Q2 2013 and held it in 12 quarters. The position peaked at $2.42M in Q3 2015. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2016.

National Planning Corporation reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2016 after selling out during the quarter.
National Planning Corporation sold 7,689 iShares US Pharmaceuticals ETF shares in Q2 2016, an estimated $343K.
National Planning Corporation first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 12 quarters.
National Planning Corporation's iShares US Pharmaceuticals ETF position peaked at $2.42M in Q3 2015.
87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2016.

Based on National Planning Corporation's 13F filing for Q2 2016, filed 9 Aug 2016.